Related Experiment Video
Updated: Oct 10, 2025

14:55
Measurement of Mitochondrial Oxygen Consumption in Permeabilized Fibers of Drosophila Using Minimal Amounts of Tissue
Published on: April 7, 2018
12.1K
Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From Drosophila Models
Sharifah Anoar1, Nathaniel S Woodling1, Teresa Niccoli1
1Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, United Kingdom.
Frontiers in Neuroscience
|December 13, 2021
Summary
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) share mitochondrial dysfunction. Drosophila models are crucial for understanding how FTD/ALS mutations impact mitochondrial biology and disease progression.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative diseases with overlapping genetic and clinical features.
- Mitochondrial dysfunction is a common pathological hallmark observed in both FTD and ALS patients and animal models.
Purpose of the Study:
- To review how mutations associated with FTD/ALS disrupt mitochondrial function.
- To highlight the pivotal role of Drosophila models in understanding these disruptions.
Main Methods:
- Review of recent studies on FTD/ALS and mitochondrial dysfunction.
- Analysis of induced pluripotent stem cell (iPSC) and animal models, with a focus on Drosophila.
- Examination of genetic tools and rapid generation time of Drosophila for disease modeling.
Main Results:
- Patient-derived iPSC models exhibit mitochondrial abnormalities.
- Similar mitochondrial defects are found in various animal models of FTD/ALS.
- Drosophila models have been instrumental in elucidating the role of disease-associated mutations in mitochondrial biology.
Conclusions:
- Mutations linked to FTD/ALS significantly impair mitochondrial function.
- Drosophila melanogaster serves as a powerful model organism for studying the molecular mechanisms of FTD/ALS-related mitochondrial dysfunction.

